MYGN profile · all as-reported value updates
MYRIAD GENETICS INC (MYGN) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Net income | 2017 | 21,800,000 | 17,400,000 | -4,400,000 | -20.18% | revised comparative figure | 0001564590-17-017026 0001564590-19-031849 | 3 filed observations examined for this concept and period. |
| Operating income | 2017 | 49,400,000 | 44,000,000 | -5,400,000 | -10.93% | revised comparative figure | 0001564590-17-017026 0001564590-19-031849 | 3 filed observations examined for this concept and period. |
| Operating income | 2016 | 166,800,000 | 153,400,000 | -13,400,000 | -8.03% | revised comparative figure | 0001193125-16-677859 0001564590-18-022312 | 3 filed observations examined for this concept and period. |
| Net income | 2016 | 125,300,000 | 117,200,000 | -8,100,000 | -6.46% | revised comparative figure | 0001193125-16-677859 0001564590-18-022312 | 3 filed observations examined for this concept and period. |
| Revenue | 2017 | 769,900,000 | 728,700,000 | -41,200,000 | -5.35% | revised comparative figure | 0001564590-18-022312 0001564590-19-031849 | 2 filed observations examined for this concept and period. Earliest observation is a comparative value in a later annual filing. |
| Revenue | 2018 | 772,600,000 | 743,700,000 | -28,900,000 | -3.74% | revised comparative figure | 0001564590-18-022312 0001564590-20-040011 | 3 filed observations examined for this concept and period. |
| Operating income | 2018 | 118,700,000 | 121,900,000 | 3,200,000 | +2.63% | revised comparative figure | 0001564590-18-022312 0001564590-20-040011 | 3 filed observations examined for this concept and period. |
| Net income | 2018 | 131,100,000 | 133,300,000 | 2,200,000 | +1.65% | revised comparative figure | 0001564590-18-022312 0001564590-20-040011 | 3 filed observations examined for this concept and period. |
| Liabilities | 2017 | 446,600,000 | 440,900,000 | -5,700,000 | -1.28% | revised comparative figure | 0001564590-17-017026 0001564590-18-022312 | 2 filed observations examined for this concept and period. |
| Assets | 2017 | 1,224,400,000 | 1,208,900,000 | -15,500,000 | -1.27% | revised comparative figure | 0001564590-17-017026 0001564590-18-022312 | 2 filed observations examined for this concept and period. |
| Stockholders' equity | 2017 | 778,200,000 | 768,400,000 | -9,800,000 | -1.26% | revised comparative figure | 0001564590-17-017026 0001564590-18-022312 | 2 filed observations examined for this concept and period. |
| Stockholders' equity | 2016 | 748,100,000 | 739,600,000 | -8,500,000 | -1.14% | revised comparative figure | 0001193125-16-677859 0001564590-18-022312 | 3 filed observations examined for this concept and period. |